O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$1.1B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
148
New
Increased
Reduced
Closed

Top Buys

1 +$234M
2 +$105M
3 +$77M
4
BLUE
bluebird bio
BLUE
+$66.5M
5
CAH icon
Cardinal Health
CAH
+$57.3M

Top Sells

1 +$188M
2 +$158M
3 +$144M
4
BIIB icon
Biogen
BIIB
+$122M
5
NPSP
NPS PHARMACEUTICALS INC
NPSP
+$106M

Sector Composition

1 Healthcare 85.68%
2 Technology 0.16%
3 Financials 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$573M 4.89%
8,882,800
+1,194,100
2
$510M 4.35%
1,206,800
-287,900
3
$487M 4.16%
3,049,000
+341,000
4
$470M 4.01%
1,578,187
+89,987
5
$366M 3.12%
3,172,000
-485,600
6
$335M 2.86%
3,411,400
-838,100
7
$332M 2.83%
4,408,000
+100,000
8
$331M 2.83%
1,385,000
+215,000
9
$319M 2.73%
8,857,551
10
$316M 2.7%
1,120,000
-365,000
11
$313M 2.67%
6,678,000
12
$303M 2.59%
4,697,800
+160,000
13
$282M 2.41%
4,814,900
-516,200
14
$243M 2.08%
1,811,700
+216,000
15
$242M 2.06%
5,162,000
+279,600
16
$240M 2.05%
2,622,500
-526,800
17
$240M 2.05%
13,511,000
+13,191,000
18
$234M 1.99%
3,861,400
+150,000
19
$233M 1.99%
3,459,100
-122,800
20
$232M 1.98%
5,833,600
-135,000
21
$223M 1.91%
1,236,684
-281,261
22
$207M 1.77%
3,687,300
-272,700
23
$207M 1.76%
1,247,800
24
$192M 1.64%
14,342,447
25
$190M 1.63%
421,800
+31,600